In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From ELITechGroup SAS

Heart Failure: Strength in Devices

With the aging of the population, heart failure has emerged as a key public health concern. Several device-based technologies are poised to positively impact both ends of the disease spectrum, enabling earlier diagnosis and treatment, and providing more treatment options for those in later stages of the disease.

Medical Device

Deal Statistics Quarterly, Q2 2001

In Vivo presents another installment of our quarterly review of dealmaking--in this case April 2001-June 2001. Our data comes from Windhover's Strategic Transactions Database. We include medical device financings by industry segment and by deal type; medical device M&A; diagnostic financings and alliances by product category; pharma and biotech alliances by technology segment; pharma and biotech alliances by deal type, and pharma and biotech financings by market segment and therapeutic category.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Other Names / Subsidiaries
    • Amplimedical S.p.A.
    • ELITechGroup Clinical Systems SAS
    • ELITechGroup Biomedical Systems
    • ELITechGroup B.V.
    • ELITech Italia
    • ELITech Latin America
    • ELITech Microbio
    • Epoch Biosciences
    • Nanogen
    • Seppim
    • Serfib
    • Wescor
UsernamePublicRestriction

Register